Τετάρτη, 22 Ιανουαρίου 2020

Δευτέρα, 25 Σεπτεμβρίου 2017 NEW Hotel, Αθήνα

To πρόγραμμα του συνεδρίου

Δευτέρα, 25 Σεπτεμβρίου 2017

09:00 – 09:30

REGISTRATION AND COFFEE

09:30 – 09:40
WELCOME & INTRODUCTORY REMARKS

"Setting the scene: the landscape of rare diseases in Greece"

Moderator:
Panagiotis Stafylas, CEO, ΗΤΑ & eHealth Consultant, Healthink LP

09:40 – 10:30
OPENING REMARKS
  • Georgios Giannopoulos*, Secretary General, Ministry of Health
  • Konstantinos Panagoulias, General Manager, Vian, Vice-President, Vianex
  • Christos Dakas, Vice President, Pharma Innovation Forum, CEO Shire Greece
  • Antonis Avgerinos, Secretary General of the Scientific Society for Rare Diseases & Orphan Drugs (EESPOF), President of the Hellenic Red Cross
  • Aikaterini Theoharis, President, Panhellenic Association of Patients & Friends suffering from Lysosomal Diseases "The Solidarity"
SESSION I |RARE DISEASES: CURRENT LANDSCAPE IN EUROPE AND IN GREECE, EFFECTS ON PATIENT ACCESS
10:30 – 12:30

"Comprehensive review of the current landscape in Greece: availability, reimbursement, pricing issues"

  • Isidoros Kougioumtzoglou, Market Access Manager, Vianex, Member of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

"Treating rare diseases in Greece: real life scientific data"

  • Ilias Gountas, Scientific Associate, Doctoral Candidate, Laboratory of Hygiene, Epidemiology and Medical Statistics, Medical School - University of Athens

"Looking directly the hospital clawback mechanism and how this affects patient access"

  • Didier Cochet, General Manager, Sanofi-Genzyme

"Plasma derived medicinal products - global environment and specificities to be considered for ensuring access to care"

  • Bruno Santoni, Executive Director, Plasma Protein Therapeutics Association (PPTA) Europe

"Access to Therapy - Rare Diseases Patient perspective"

  • Marianna Lambrou, Founder & ex-President of the Greek Alliance for Rare Diseases, President of the Tuberous Sclerosis Association of Greece

Q & As

12:30 – 13:30

LIGHT LUNCH

SESSION II |SETTING REIMBURSEMENT STRATEGIES IN A CHALLENGING LANDSCAPE
13:30 – 14:30

"Financial burden and challenges treating rare diseases in Greek healthcare system"

  • Ilias Giannoglou*, Vice President National Organization of Medicines (EOF)

"Rare diseases in secondary care"

  • Anastasia Balasopoulou, General Manager Hippokrateio Hospital, ΜSc in Decision Making, Operational Research Department, London School of Economics

"Orphan drugs, BDPs and plasma therapies: inelastic and predictable spending for absolutely vital treatments"

  • Marianna Konstantinidi, General Manager, CSL Behring

Q & As

CREATING A SUSTAINABLE ENVIRONMENT FOR RARE DISEASES PATIENTS
14:30 – 15:45
Panel Discussion

Moderator:
Panagiotis Stafylas, CEO, ΗΤΑ & eHealth Consultant, Healthink LP

  • Panayiotis Georgakopoulos, Vice President of the National Organization for the Provision of Healthcare Services (EOPYY)
  • Despoina Makridaki, A’ Vice President National Organization of Medicines (EOF), President of the Pan-Hellenic Association of Hospital Pharmacists (PEFNI)
  • Dimitris Pantazis, CEO of the Institute of Pharmaceutical Research and Technology (IFET)
  • Athanassios Vozikis, Assistant Professor, Director of the Laboratory of Health Economics and Management, Economics Dept., School of Economics, Business and International Studies, University of Piraeus
  • Olympios Papadimitriou, General Manager, Novo Nordisk Hellas LTD
KEY CHALLENGES IDENTIFIED, LESSONS LEARNED AND NEXT STEPS
15:45 – 16:00
  • Panagiotis Stafylas, CEO, ΗΤΑ & eHealth Consultant, Healthink LP

Δείτε τους όρους χρήσης. Επικοινωνήστε μαζί μας.

© 2020 Boussias Communications, all rights reserved. Κλεισθένους 338, 153 44 Γέρακας, info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team